NextGen Healthcare, Inc. provides software and services for ambulatory healthcare services in the United States. The company offers patient engagement solutions, comprising of NextGen PxP Portal, NextGen Patient Self Scheduling, NextGen Pay, and NextGen Virtual Visits; clinical care solutions, including NextGen Enterprise HER, NextGen Mobile, NextGen Office, NextGen Behavioral Health Suite, NextGen Orthopedic Suite, and QSIDental Web and QSIDental PM; and financial management solutions, such as NextGen Enterprise PM and NextGen Clearinghouse Solutions. It also provides population health solutions, consisting of NextGen Population Health Core, NextGen Population Health Value Management, and NextGen Population Health Patient Care Management; connected health solutions, comprising of NextGen Connect Integration Engine, NextGen Share, and NextGen Health Data Hub; and managed services, such as NextGen Managed Cloud Services and NextGen Revenue Cycle Management Services. . In addition, the company offers provides training, project management, functional and detailed specification preparation, configuration, testing, and installation services; and client and support services. Further, it provides consulting services, which include physician, professional, and technical consulting; assisting clients to optimize their staffing and software solutions; enhancing financial and clinical outcomes; achieving regulatory requirements; and meeting the requirements of healthcare reform. It serves managed service organizations, independent physician associations, accountable care organizations, veterans service organizations, dental service organizations, ambulatory care centers, and community health centers through a direct sales force and reseller channel. The company was formerly known as Quality Systems, Inc. and changed its name to NextGen Healthcare, Inc. in September 2018. NextGen Healthcare, Inc. was incorporated in 1974 and is headquartered in Atlanta, Georgia.
IPO Year:
Exchange: NASDAQ
Website: nextgen.com
| Date | Price Target | Rating | Analyst |
|---|---|---|---|
| 8/28/2023 | $21.00 | Overweight | Cantor Fitzgerald |
| 4/12/2023 | $24.00 | Overweight | Stephens |
| 10/21/2022 | $20.00 | Neutral | Piper Sandler |
| 9/7/2022 | $20.00 | Hold | Truist |
| 5/6/2022 | $26.00 | Neutral → Buy | Guggenheim |
| 4/14/2022 | Neutral | Guggenheim | |
| 1/6/2022 | $22.00 | Mkt Perform → Outperform | SVB Leerink |
| 1/6/2022 | Market Perform → Outperform | SVB Leerink | |
| 7/30/2021 | $21.00 → $19.00 | Sector Perform | RBC Capital |